Charles Schwab Investment Management Inc 4 D Molecular Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 302,205 shares of FDMT stock, worth $6.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302,205
Previous 268,638 12.5%
Holding current value
$6.34 Million
Previous $5.44 Million 76.92%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$17.03 - $35.87 $571,646 - $1.2 Million
33,567 Added 12.5%
302,205 $9.63 Million
Q4 2023

Feb 06, 2024
BUY
$9.76 - $21.25 $98,868 - $215,262
10,130 Added 3.92%
268,638 $5.44 Million
Q3 2023

Nov 08, 2023
SELL
$12.64 - $19.76 $95,672 - $149,563
-7,569 Reduced 2.84%
258,508 $3.29 Million
Q2 2023

Aug 09, 2023
BUY
$15.16 - $23.26 $727,240 - $1.12 Million
47,971 Added 21.99%
266,077 $4.81 Million
Q1 2023

May 11, 2023
BUY
$15.45 - $23.19 $18,632 - $27,967
1,206 Added 0.56%
218,106 $3.75 Million
Q4 2022

Feb 13, 2023
BUY
$6.85 - $25.46 $40,812 - $151,690
5,958 Added 2.82%
216,900 $4.82 Million
Q3 2022

Nov 14, 2022
BUY
$6.96 - $11.48 $242,493 - $399,974
34,841 Added 19.78%
210,942 $1.7 Million
Q2 2022

Aug 15, 2022
SELL
$5.68 - $15.99 $76,736 - $216,024
-13,510 Reduced 7.13%
176,101 $1.23 Million
Q1 2022

May 13, 2022
BUY
$13.16 - $22.64 $69,905 - $120,263
5,312 Added 2.88%
189,611 $2.87 Million
Q4 2021

Feb 11, 2022
BUY
$19.56 - $32.94 $765,676 - $1.29 Million
39,145 Added 26.97%
184,299 $4.04 Million
Q3 2021

Nov 16, 2021
BUY
$22.73 - $36.04 $1.86 Million - $2.95 Million
81,934 Added 129.6%
145,154 $3.92 Million
Q2 2021

Aug 16, 2021
BUY
$22.2 - $42.29 $116,616 - $222,149
5,253 Added 9.06%
63,220 $1.52 Million
Q1 2021

May 17, 2021
BUY
$35.94 - $52.67 $2.08 Million - $3.05 Million
57,967 New
57,967 $2.52 Million

Others Institutions Holding FDMT

# of Institutions
157
Shares Held
50.3M
Call Options Held
718K
Put Options Held
370K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $680M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email